Source:http://linkedlifedata.com/resource/pubmed/id/11318574
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-4-24
|
pubmed:abstractText |
A clinical trial to compare the effectiveness of 4- and 6-mo repeated treatment with albendazole 600 mg (Zentel, SmithKline Beecham) or mebendazole 600 mg (Vermox, Janssen) on geohelminth infections was carried out on children in 6 primary schools; the study included 1,186 children, ages 4 to 19 yr. Kato-Katz examination was performed on stool samples before and after treatment. Overall, albendazole produced better cure rates and egg reduction rates for geohelminths. The cure rates for albendazole were 92.4% for hookworm infection, 83.5% for Ascaris lumbricoides, and 67.8% for Trichuris trichiura. Mebendazole given either 2 or 3 times in a year had cure rates of 50 and 55.0% (respectively) for hookworm, 79.6 and 97.5% for A. lumbricoides, and 60.6 and 68.3% for T. trichiura infection. The geometric mean intensity of hookworm eggs per gram (epg) of stool decreased by 96.7% after albendazole treatment compared with 66.3 and 85.1%, respectively, for 2 or 3 doses of mebendazole (P < 0.05) over the same period. Reductions in epg for A. lumbricoides and T. trichiura were comparable for both drugs. Our results indicate that treatment with albendazole at a 6-mo interval was more effective than mebendazole regimens and may be the best choice for use in the control of the 3 geohelminths.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-3395
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
413-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11318574-Adolescent,
pubmed-meshheading:11318574-Adult,
pubmed-meshheading:11318574-Albendazole,
pubmed-meshheading:11318574-Anthelmintics,
pubmed-meshheading:11318574-Child,
pubmed-meshheading:11318574-Child, Preschool,
pubmed-meshheading:11318574-Drug Administration Schedule,
pubmed-meshheading:11318574-Female,
pubmed-meshheading:11318574-Helminthiasis,
pubmed-meshheading:11318574-Humans,
pubmed-meshheading:11318574-Intestinal Diseases, Parasitic,
pubmed-meshheading:11318574-Kenya,
pubmed-meshheading:11318574-Male,
pubmed-meshheading:11318574-Mebendazole,
pubmed-meshheading:11318574-Prevalence,
pubmed-meshheading:11318574-Seasons
|
pubmed:year |
2001
|
pubmed:articleTitle |
A comparative study of different albendazole and mebendazole regimens for the treatment of intestinal infections in school children of Usigu Division, western Kenya.
|
pubmed:affiliation |
Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|